Precise targeting of HIV broadly neutralizing antibody precursors in humans

Go back to Resources

Precise targeting of HIV broadly neutralizing antibody precursors in humans

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Population Pharmacokinetics of Alfentanil in Children

Go back to Resources

Population Pharmacokinetics of Alfentanil in Children

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines

Go back to Resources

Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines

Authors:

Volume:

Issue:

Journal:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Resources

Read more about Resources

Explore our latest insights, case studies, scientific publications, and more.

eBook: A Blueprint for Success in Cell and Gene Therapy Trials

Read more about eBook: A Blueprint for Success in Cell and Gene Therapy Trials

Data Management Agent

Read more about Data Management Agent

The Veridix Data Management Agent empowers data management teams to work faster, more effectively, and more consistently across studies. By automating repetitive tasks - such as discrepancy detection, query review, and data status tracking - the agent enables earlier issue detection and resolution, reduces manual burden, and improves coordination with clinical, safety, and programming teams. Scalable and configurable by study, it drives speed and quality at every trial milestone.

Request for Proposal (RFP)

Read more about Request for Proposal (RFP)

New Mountain Capital Announces Growth Partnership with Emmes

Go back to Newsroom

New Mountain Capital Announces Growth Partnership with Emmes

Partnership to Support Emmes’ Next Phase of Tech-Enabled Growth

Download Go back to Newsroom

Emmes Introduces Telehealth Capabilities into Advantage eClinical

Go back to Newsroom

Emmes Introduces Telehealth Capabilities into Advantage eClinical

The latest upgrade is part of wider goals to create the industry’s first unified digital data platform for decentralized and hybrid trials

Download Go back to Newsroom

Emmes Appoints Peter Ronco as Chief Executive Officer

Go back to Newsroom

Emmes Appoints Peter Ronco as Chief Executive Officer

Ronco’s Global Pharmaceutical Experience Will Support the Next Chapter of Emmes’ Growth and Technology Enablement

Rockville, MD, September 20, 2023 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Peter Ronco has been named Chief Executive Officer, effective immediately.

Download Go back to Newsroom

Subscribe to